Presentation slides and video from the 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Genitourinary Cancers were presented virtually on March 22, 2023.
Program Organizers
Target Audience
The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.
Program Learning Objectives
You can view the program agenda here.
Please note on-demand recordings are not available for continuing education credits.
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Genitourinary Cancers; Date: March 22, 202300:59:56
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Genitourinary Cancers; Speaker: David Braun, MD, PhD; Date: March 22, 202300:37:05
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Genitourinary Cancers; Speaker: Brian Rini, MD; Date: March 22, 202300:22:09
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Genitourinary Cancers; Speaker: Ali Khaki, MD; Date: March 22, 202300:30:28
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Genitourinary Cancers; Speaker: Samuel Funt, MD; Date: March 22, 202300:29:57
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Genitourinary Cancers; Speaker: Julie Graff, MD; Date: March 22, 202300:27:19
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Genitourinary Cancers; Speaker: Pedro Barata, MD, MSc; Date: March 22, 202300:24:46
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us